Published in Hypertension on March 27, 2006
Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA (2013) 3.55
Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension (2008) 2.96
Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study. Am J Hypertens (2012) 2.01
Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures. J Hypertens (2009) 1.57
Predicting out-of-office blood pressure level using repeated measurements in the clinic: an observational cohort study. J Hypertens (2014) 1.53
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2007) 1.49
Job strain and ambulatory blood pressure: a meta-analysis and systematic review. Am J Public Health (2013) 1.31
Franz Volhard lecture: should doctors still measure blood pressure? The missing patients with masked hypertension. J Hypertens (2008) 1.31
Inter-arm blood pressure differences compared with ambulatory monitoring: a manifestation of the 'white-coat' effect? Br J Gen Pract (2013) 1.26
Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens (2014) 1.25
Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index? Eur J Nutr (2007) 1.24
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care (2013) 1.16
Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006. Hypertension (2010) 1.12
White coat hypertension is more risky than prehypertension: important role of arterial wave reflections. Hypertension (2013) 1.05
Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol (2011) 1.03
Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol (2013) 1.03
Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): a cluster randomized trial. Contemp Clin Trials (2012) 0.99
Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study. Am J Hypertens (2014) 0.97
Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review. Ann Intern Med (2015) 0.97
Renal protection in diabetes: lessons from ONTARGET. Cardiovasc Diabetol (2010) 0.95
Home blood pressure monitoring: how good a predictor of long-term risk? Curr Hypertens Rep (2011) 0.95
Masked Uncontrolled Hypertension in CKD. J Am Soc Nephrol (2015) 0.94
Blood pressure measurement: clinic, home, ambulatory, and beyond. Am J Kidney Dis (2012) 0.94
Clinical implications of ambulatory and home blood pressure monitoring. Korean Circ J (2010) 0.91
Predictors of the Home-Clinic Blood Pressure Difference: A Systematic Review and Meta-Analysis. Am J Hypertens (2015) 0.89
Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study. Hypertension (2016) 0.89
Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses. Curr Hypertens Rep (2013) 0.88
Reproducibility of blood pressure dipping: relation to day-to-day variability in sleep quality. J Am Soc Hypertens (2013) 0.85
Prevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy. Eur J Prev Cardiol (2012) 0.85
Exercise Hypertension. Pulse (Basel) (2014) 0.84
Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines for the management of arterial hypertension. Vasc Health Risk Manag (2007) 0.84
Prevalence and factors affecting home blood pressure documentation in routine clinical care: a retrospective study. BMC Health Serv Res (2010) 0.83
Pragmatic Method Using Blood Pressure Diaries to Assess Blood Pressure Control. Ann Fam Med (2016) 0.82
What is the optimal interval between successive home blood pressure readings using an automated oscillometric device? J Hypertens (2009) 0.81
Relative utility of home, ambulatory, and office blood pressures in the prediction of end-organ damage. Am J Hypertens (2007) 0.81
Alterations in diastolic function in masked hypertension: findings from the masked hypertension study. Am J Hypertens (2013) 0.80
Should white-coat hypertension in diabetes be treated? Pro. Diabetes Care (2009) 0.80
The applicability of home blood pressure measurement in clinical practice: a review of literature. Vasc Health Risk Manag (2007) 0.80
Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hypertens (2015) 0.79
Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study. BMC Nephrol (2012) 0.79
Out-of-office blood pressure: from measurement to control. Integr Blood Press Control (2012) 0.79
Home blood pressure monitoring: Australian Expert Consensus Statement. J Hypertens (2015) 0.79
Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension. Medicine (Baltimore) (2015) 0.78
The Utility of Ambulatory Blood Pressure Monitoring for Diagnosing White Coat Hypertension in Older Adults. Curr Hypertens Rep (2015) 0.78
Mobile personal health system for ambulatory blood pressure monitoring. Comput Math Methods Med (2013) 0.78
Ambulatory blood pressure monitoring is recommended in the clinical management of children with a solitary functioning kidney. Pediatr Nephrol (2014) 0.77
Metabolic risk factors and masked hypertension in the general population: the Finn-Home study. J Hum Hypertens (2014) 0.77
The evolution and refinement of traditional risk factors for cardiovascular disease. Cardiol Rev (2012) 0.77
High Prevalence of Hypertension in a Danish Population Telemedical Home Measurement of Blood Pressure in Citizens Aged 55-64 Years in Holstebro County. Am J Hypertens (2015) 0.77
Type 2 Diabetes Mellitus and Thoracic Aortic Aneurysm and Dissection: An Observational Population-Based Study in Spain From 2001 to 2012. Medicine (Baltimore) (2016) 0.77
Treatment Resistant Hypertension. Ethn Dis (2015) 0.76
Insufficient control of morning home blood pressure in Japanese patients with hypertension associated with diabetes mellitus. J Diabetes Investig (2010) 0.76
Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance? Pediatr Nephrol (2007) 0.75
White-coat and masked hypertension: selective elevation of blood pressure or an arbitrarily partitioned continuum? Hypertension (2006) 0.75
New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil. Integr Blood Press Control (2012) 0.75
Hypertension. Tackling challenges in the diagnosis and management of hypertension in 2012. Nat Rev Cardiol (2012) 0.75
Should we screen for masked hypertension in patient with vascular disease? Vasc Health Risk Manag (2010) 0.75
Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories. Hypertension (2006) 0.75
Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries. Cardiol Clin (2017) 0.75
Cardiopulmonary Exercise Test in Patients with Hypertension: Focused on Hypertensive Response to Exercise. Pulse (Basel) (2015) 0.75
Higher Blood Pressure Variability in White Coat Hypertension; from the Korean Ambulatory Blood Pressure Monitoring Registry. Korean Circ J (2016) 0.75
Difficulties in achieving arterial hypertension control. Maedica (Buchar) (2011) 0.75
Does home blood pressure monitoring improve patient outcomes? A systematic review comparing home and ambulatory blood pressure monitoring on blood pressure control and patient outcomes. Integr Blood Press Control (2015) 0.75
White coat effect and white coat hypertension: one and the same? Malays Fam Physician (2008) 0.75
Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH). Med Arch (2016) 0.75
Prospective Register Of patients undergoing repeated OFfice and Ambulatory Blood Pressure Monitoring (PROOF-ABPM): protocol for an observational cohort study. BMJ Open (2016) 0.75
Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data. BMJ Open (2014) 0.75
Home blood pressure monitoring as an intervention to control hypertension: comment on "Home blood pressure management and improved blood pressure control". Arch Intern Med (2011) 0.75
Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study. Int J Cardiol (2016) 0.75
Renal denervation in the treatment of resistant arterial hypertension. Wien Med Wochenschr (2014) 0.75
Blood Pressure Response to Exercise and Cardiovascular Disease. Curr Hypertens Rep (2017) 0.75
Prevalence and reproducibility of differences between home and ambulatory blood pressure and their relation with hypertensive organ damage. J Hum Hypertens (2017) 0.75
Clinical significance of home blood pressure and its possible practical application. Clin Exp Nephrol (2013) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation (2005) 4.69
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension (2009) 2.71
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension (2006) 2.65
Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis. Am J Hypertens (2013) 2.27
Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens (2014) 2.25
Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet (2010) 2.24
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24
Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation (2012) 2.21
Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension (2002) 2.15
The contribution of major risk factors and job strain to occupational class differences in coronary heart disease incidence: the MONICA Brianza and PAMELA population-based cohorts. Occup Environ Med (2010) 2.11
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol (2005) 1.88
Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension (2013) 1.87
The sympathetic nervous system and the metabolic syndrome. J Hypertens (2007) 1.80
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist (2012) 1.79
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension (2007) 1.77
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension (2008) 1.65
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension (2005) 1.54
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens (2009) 1.53
Flow-mediated dilatation as a biomarker for cardiovascular risk in hypertension. J Hypertens (2008) 1.44
Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand? J Clin Hypertens (Greenwich) (2013) 1.44
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens (2009) 1.43
Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: findings from 12 Italian population samples. Am J Epidemiol (2006) 1.43
Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice. J Hypertens (2004) 1.41
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens (2012) 1.37
HIV and metabolic syndrome: a comparison with the general population. J Acquir Immune Defic Syndr (2007) 1.31
Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens (2002) 1.25
New-onset diabetes and antihypertensive drugs. J Hypertens (2006) 1.18
Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE. Eur J Cardiovasc Prev Rehabil (2006) 1.15
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage. Hypertension (2011) 1.14
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Arch Intern Med (2002) 1.11
[Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score]. Ann Ist Super Sanita (2004) 1.10
Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens (2012) 1.09
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens (2006) 1.09
Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system? J Hypertens (2009) 1.08
Sympathetic regulation of vascular function in health and disease. Front Physiol (2012) 1.07
Purification and structural characterization of 3-hydroxypropionaldehyde and its derivatives. J Agric Food Chem (2003) 1.05
Ultrasonographic backscatter of the carotid artery wall in patients with HIV infection: a pilot study. Blood Press (2010) 1.05
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol (2013) 1.05
Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens (2005) 1.05
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J Hypertens (2003) 1.04
Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol (2011) 1.03
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens (2009) 1.03
Diurnal blood pressure variation and sympathetic activity. Hypertens Res (2010) 1.02
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension. J Cardiovasc Pharmacol (2013) 1.02
Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. Eur Heart J (2010) 1.01
Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Hypertension (2002) 0.98
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens (2013) 0.94
European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens (2009) 0.91
Job strain and blood pressure in employed men and women: a pooled analysis of four northern italian population samples. Psychosom Med (2003) 0.90
Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome. World J Gastroenterol (2008) 0.90
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
Antihypertensive treatment and blood pressure in diabetic and nondiabetic patients: the lower, the better? Diabetes Care (2011) 0.90
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J Hypertens (2008) 0.90